Biofermin Pharmaceutical Co., Ltd.

City:

Kobe

Country:

Japan

Published Applications:

Last publication date:

2021-05-20

Patent Grants:

Last grant date:

2022-01-18

Top Inventors for applications by Biofermin Pharmaceutical Co., Ltd.

These are the the leading inventors for applications assigned to Biofermin Pharmaceutical Co., Ltd.:

Masaki Shimakawa 3 Kobe, Japan
Hiroshi Ohno 3 Kobe, Japan
Masaki Shimakawa 3 Kobe-shi, Japan
Hiroshi Ohno 3 Kobe-shi, Japan

Yoshiki Tanaka 2 Kobe, Japan
Yoshiki Tanaka 2 Kobe-shi, Japan
Tomohiro Kawahara 1 Kobe, Japan
Atsushi Nakajima 1 Yokohama, Japan

Takaomi Kessoku 1 Yokohama, Japan
Ayako Maeda 1 Kobe, Japan
Takaomi KESSOKU 1 Yokohama-shi, Japan
Ayako Maeda 1 Kobe-shi, Japan

Tomohiro Kawahara 1 Kobe-shi, Japan
Yosuke Oikawa 1 Kobe-shi, Japan
Atsushi Nakajima 1 Yokohama-shi, Japan
Yosuke Oikawa 1 Kobe, Japan

Recent patent applications by Biofermin Pharmaceutical Co., Ltd.

Biofermin Pharmaceutical Co., Ltd. based in Kobe, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-05-20 ✅ Patent 11,224,622 granted on 2022-01-18

US20210145897A1

Human necessities

Agent for preventing or treating fat-associated diseases and/or inflammation

#2 | 2020-10-29 ✅ Patent 11,219,650 granted on 2022-01-11

US20200338143A1

Human necessities

Agent for preventing or treating small intestinal injury induced by specific NSAID and PPI

#3 | 2019-08-29 ✅ Patent 11,376,287 granted on 2022-07-05

US20190262408A1

Human necessities

Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation

Also check out Biofermin Pharmaceutical Co., Ltd.'s (Kobe, Japan) applicant profile with 3 patent applications submitted.

AssigneeID:

369883 ⎘